Recarbrio Drug Interactions
Currently displaying a list of 37 drugs known to interact with Recarbrio (cilastatin / imipenem / relebactam).
- 14 major drug interactions
- 21 moderate drug interactions
- 2 minor drug interactions
Medications known to interact with Recarbrio
Note: Showing generic names only.
- amifampridine
- aminophylline
- anisindione
- bcg
- bupropion
- cholera vaccine, live
- cyclosporine
- dicumarol
- divalproex sodium
- dyphylline
- entecavir
- estradiol
- ethinyl estradiol
- evening primrose
- fecal microbiota spores, live
- fecal microbiota, live
- fluphenazine
- ganciclovir
- ginkgo
- indium oxyquinoline in-111
- iohexol
- iomeprol
- iopamidol
- lindane topical
- metrizamide
- mycophenolate mofetil
- mycophenolic acid
- oxtriphylline
- pemetrexed
- polyethylene glycol 3350 with electrolytes
- probenecid
- theophylline
- tramadol
- typhoid vaccine, live
- valganciclovir
- valproic acid
- warfarin
Recarbrio alcohol/food interactions
There is 1 alcohol/food interaction with Recarbrio (cilastatin / imipenem / relebactam).
Recarbrio disease interactions
There are 6 disease interactions with Recarbrio (cilastatin / imipenem / relebactam) which include:
More about Recarbrio (cilastatin / imipenem / relebactam)
- Recarbrio consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: carbapenems/beta-lactamase inhibitors
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.